At present, various giants in the IVD market are competing the five mainstream market segments: biochemistry, immunity, molecular, POCT, and clinical testing.

With the application of the latex-enhanced immunoturbidimetry and the enzyme immunoassay amplification, the sensitivity of biochemical test items is greatly improved. Representative products applied in the biochemical technology platform in 2019-2020 are as follows:

Enlightening Lab Med - The 6th IVD Youth Entrepreneur Forum (ELMY) is scheduled to be held at Primus Hotel Nanchang International Expo City on May 26 in 2023.

On February 22, the National Development and Reform Commission announced the list of the 29th of newly identified and all national enterprise technology centers. More than 20 IVD-related enterprises are on the list!

Recently, Chongqing Federation of Industry and Commerce released the "Top 100 list of Chongqing Private Enterprises' Science and Technology Innovation Index", and Zybio ranked 3rd on the list.

The overall overseas revenue of listed china companies has a three-year CAGR of more than 25%, and the export volume will rebound significantly in 2022.

On July 23, 2022, the China Enterprise Evaluation Association released the "2021 China Top 500 New Economy Enterprises" list. China's Top 500 New Economy Enterprises is hosted by the China Enterprise Evaluation Association

On Sep. 25th, Upper Biotech applied for IPO was accepted by Shanghai Stock Exchange. At present, it has 7 listed enterprise on STAR Market, 2 registered upcoming companies and 5 waitings.

Tests for the coronavirus (COVID-19) continue to roll in as the U.S. faces a public health crisis. Thermo Fisher Scientific and Mayo Clinic are the latest with diagnostic contributions. Waltham, MA-based Thermo Fisher is the second company

Biocartis announced it has entered into an agreement with AstraZeneca. The goal of the agreement will be to obtain faster lung cancer molecular diagnostic biomarker results in Europe. A prospective lung cancer study with the Idylla EGFR Mut